Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
1. Eli Lilly is suing four telehealth companies selling compounded versions of its drugs. 2. The lawsuits accuse the companies of marketing untested, deceptive alternatives to Lilly's offerings. 3. Lilly seeks to prevent these companies from selling tirzepatide formulations. 4. Compounding began during a drug shortage, attracting patients seeking alternatives. 5. Lilly alleges unlawful practices and influence over prescribing decisions by these companies.